# Schedules of Controlled Substances: Placement of MAB-CHMINACA Into Schedule I
> **Proposed Rule** · Notice of proposed rulemaking. · Published 2018-01-30 · 83 FR 4406
## Document
- **Document number:** 2018-01747
- **Category:** scheduling
- **Type:** Proposed Rule
- **Action:** Notice of proposed rulemaking.
- **Citation:** 83 FR 4406
- **Publication date:** 2018-01-30
## Abstract

The Drug Enforcement Administration proposes placing N-(1- amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (other names: MAB-CHMINACA; ADB-CHMINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle MAB-CHMINACA.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2018/01/30/2018-01747/schedules-of-controlled-substances-placement-of-mab-chminaca-into-schedule-i)
---
*AI Analytics · CC0 1.0*